TOP1 and cancer: TDP1 plays a crucial role in the repair of DNA lesions formed by antitumor drugs such as the TOP1 inhibitors camptothecin, topotecan (a TOP1 poison in clinical use), and irinotecan; therefore, TDP1 is a promising target for adjunctive cancer treatment.